miR-99a通过下调RRM2抑制人子宫颈癌HeLa细胞系增殖、迁移和侵袭

doi:10.16352/j.issn.1001-6325.2022.11.1737

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (11): 1737-1743.doi: 10.16352/j.issn.1001-6325.2022.11.1737

miR-99a通过下调RRM2抑制人子宫颈癌HeLa细胞系增殖、迁移和侵袭

贺春花, 刘冷^*, 张小柳

荆门市第一人民医院妇科, 湖北荆门 448000

收稿日期:2021-06-17 修回日期:2022-07-11 出版日期:2022-11-05 发布日期:2022-11-01
通讯作者: ^* liuleng1026@163.com
基金资助:
荆门市科学技术研究与开发计划(2019YDKY049)

miR-99a inhibits the proliferation, migration and invasion of cervical cancer HeLa cell line through down-regulating RRM2

HE Chun-hua, LIU Leng^*, ZHANG Xiao-liu

Department of Gynecology, Jingmen No.1 People's Hospital, Jingmen 448000, China

Received:2021-06-17 Revised:2022-07-11 Online:2022-11-05 Published:2022-11-01
Contact: ^* liuleng1026@163.com

摘要/Abstract

摘要： 目的探讨miR-99a与核糖核苷酸还原酶小亚基M2(RRM2)的靶向关系,并分析二者对人子宫颈癌(CC)HeLa细胞系增殖、侵袭及迁移的影响。方法将HeLa细胞,分为对照组(control)、阴性对照组(inhibitor-NC)、抑制miR-99a表达组(miR-99a-inhibitor)、共转染组(RRM2-siRNA+miR-99a-inhibitor)。MTT法、平板集落实验检测细胞增殖;划痕实验、Transwell小室法检测细胞迁移、侵袭;Western blot检测RRM2、细胞增殖核抗原(PCNA)、E-钙黏附蛋白(E-cadherin)、N-钙黏附蛋白(N-cadherin)、波形蛋白(vimentin)蛋白表达;免疫荧光法检测E-cadherin、N-cadherin、vimentin定位及表达;生物信息学及双荧光素酶报告基因实验验证miR-99a与RRM2靶向关系;RT-qPCR检测细胞中miR-99a、RRM2 mRNA水平。结果下调miR-99a表达,可增高HeLa细胞增殖率(100.00比128.86±4.25,P＜0.05);上调集落形成率、划痕愈合率、侵袭细胞数;增加RRM2、PCNA、N-cadherin与vimentin蛋白表达,降低E-cadherin蛋白表达(P＜0.05)。抑制RRM2表达能减轻下调miR-99a对HeLa细胞生物学行为的影响(P＜0.05)。双荧光素酶报告基因实验及RT-qPCR证实miR-99a与RRM2存在靶向关系(P＜0.05)。结论抑制miR-99a可能靶向上调RRM2表达并促进HeLa细胞增殖,有望成为CC新的潜在治疗靶点。

关键词: miR-99a, 核糖核苷酸还原酶小亚基M2, 宫颈癌细胞, 增殖, 迁移

Abstract: Objective To investigate the targeting relationship between miR-99a and ribonucleotide reductase subunit M2 (RRM2)and to analyze their effects on proliferation, invasion and migration of cervical cancer (CC)-oringinated HeLa cell line. Methods HeLa cells were divided into control group, negative control group (inhibitor-NC), inhibition of miR-99a expression group (miR-99a-inhibitor) and co-transfection group (RRM2-siRNA+miR-99a-inhibitor). MTT assay and plate colony experiment were used to detect the proliferation ability of HeLa cells. Scratch test and Transwell test were used to detect cell migration and invasion ability respectively. Western blot was used to detect protein expression of RRM2, proliferating cell nuclear antigen (PCNA), E-cadherin, N-cadherin and vimentin.Immunofluorescence method was used to detect the localization and expression of E-cadherin, N-cadherin and vimentin. Bioinformatics and dual-luciferase reporter gene experiments verified the targeting relationship between miR-99a and RRM2. RT-qPCR were used to detect the expression levels of miR-99a and RRM2 mRNA in HeLa cells in each group. Results Down-regulating the expression of miR-99a increased proliferation of HeLa cells (100.00 vs. 128.86±4.25, P＜0.05). Up-regulated colony formation improved scratch healing rate, and increased the number of invasive cells and the expression of RRM2, PCNA, N-cadherin and vimentin protein, decreased E-cadherin protein expression (P＜0.05). Inhibition of RRM2 expression reversed the effect of down-regulation of miR-99a on the biological behavior of HeLa cells(P＜0.05). Dual-luciferase reporter gene experiment and RT-qPCR confirmed that miR-99a had a targeting relationship with RRM2 (P＜0.05). Conclusions Inhibition of miR-99a may target at up-regulating the expression of RRM2 to promote the development of HeLa cells, which is expected to become a new potential therapeutic target for CC.

Key words: miR-99a, ribonucleotide reductase subunit M2, cervical cancer cell, proliferation, migration

中图分类号:

R737

贺春花, 刘冷, 张小柳. miR-99a通过下调RRM2抑制人子宫颈癌HeLa细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(11): 1737-1743.

HE Chun-hua, LIU Leng, ZHANG Xiao-liu. miR-99a inhibits the proliferation, migration and invasion of cervical cancer HeLa cell line through down-regulating RRM2[J]. Basic & Clinical Medicine, 2022, 42(11): 1737-1743.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2022.11.1737

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2022/V42/I11/1737

参考文献 14

[1]	Shi TY, Zhu ML, He J, et al. Polymorphisms of the interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women[J]. Hum Genet, 2019, 132:301-312.
[2]	崔丹丹, 于秀文, 王俊苹, 等. HPV持续感染状态对宫颈癌手术预后的影响分析[J]. 中外女性健康研究, 2019, 63:96-105.
[3]	欧阳华, 刘龙飞. miR-99a对宫颈癌Hela细胞增殖影响机制研究[J]. 中华肿瘤防治杂志, 2018, 25:170-174.
[4]	Liang WH, Li NY, Zhi Q, et al. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2[J]. Mol Carcinog, 2019, 58:461-473.
[5]	李梦熊, 邓柳枝, 梁琼. 宫颈癌细胞系Siha和C33a中RRM2表达水平与细胞对吉西他滨敏感性的相关分析[J]. 中国药房, 2015, 13:4792-4794.
[6]	Osako Y, Yoshino H, Sakaguchi T, et al. Potential tumor-suppressive role of microRNA-99a-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM2[J]. Int J Oncol, 2019, 54:1759-1770.
[7]	Tao X, Ping L, Guolian P, et al. Differential expression of miRNAs in breast cancer tissues and the effect of Xihuang Pill on the expression of candidate miRNAs in breast cancer cells in vitro[J]. J Chinese Phy, 2019, 98:1-9.
[8]	Shinden Y, Hirashima T, Nohata N, et al. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes[J]. J Human Genetics, 2020, 12:1-12.
[9]	Zhu P, Liu J, Lu M, et al. Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)[J]. Onco Targets Ther, 2019, 27:10311-10321.
[10]	徐雅杰, 张志强, 于鹤. 和厚朴酚通过上调miR-99a/b抑制HeLa细胞增殖和侵袭[J]. 医学研究杂志, 2018, 491:107-112.
[11]	Jing B, Luo Y, Lin B, et al. Establishment and applica-tion of a dynamic tumor-vessel microsystem for studying different stages of tumor metastasis and evaluating anti-tumor drugs[J]. RSC Advances, 2019, 9:17137-17147.
[12]	Zhang HG, Pan YW, Feng J, et al. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23:2003-2012.
[13]	Lu H, Lu S, Yang D, et al. miR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy[J]. Biosci Rep, 2019, 39:BSR20181374-BSR20181381. doi: 10.1042/BSR20181374.
[14]	汤琳. 核糖核苷酸还原酶M2的表达及临床病理因素与子宫颈鳞癌预后关系的研究[D]. 浙江:宁波大学, 2019:24-26.

[1]	杨良权, 于淼, 姜茜, 张明慧, 杨海松. miR-504调控蛋白酶体激活因子抑制人乳腺癌细胞系MCF-7增殖及迁移[J]. 基础医学与临床, 2023, 43(1): 95-101.
[2]	贺晶, 李艳, 王延峰, 鲍慧. FABP4表达上调促进人子宫内膜癌细胞系HEC-1-A增殖和迁移[J]. 基础医学与临床, 2022, 42(9): 1356-1361.
[3]	张晓雷, 刘静, 李朝萍. Circ_0032821参与索拉非尼抑制乳腺癌细胞系T47D增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(9): 1350-1354.
[4]	钟金鹏, 杨莉, 王辉波, 陈红健, 李金伟, 文明洪, 吕云波. HMGB1减弱丹参酮ⅡA对大鼠心肌缺血/再灌注损伤的缓解作用[J]. 基础医学与临床, 2022, 42(9): 1333-1338.
[5]	王娟, 张晓燕, 朱爱华, 于宏波, 范新丹, 汤春辉, 姚秀芳. Ku70高表达促进人卵巢癌细胞系的增值并与卵巢癌患者不良预后相关[J]. 基础医学与临床, 2022, 42(9): 1391-1399.
[6]	沈永华, 汪峻峰, 程泽星, 冯娟娟. 秦皮甲素抑制人鼻咽癌细胞系HNE-3增殖[J]. 基础医学与临床, 2022, 42(8): 1237-1242.
[7]	谢思安, 陈奕阳, 徐俊玄, 宁婷婷, 张楠, 朱圣韬, 张澍田. PTOV1表达水平对结直肠癌患者预后的影响[J]. 基础医学与临床, 2022, 42(8): 1176-1181.
[8]	江宁, 郭钧, 刘铖, 周举. 莪术醇抑制人骨肉瘤细胞系的增殖和促凋亡[J]. 基础医学与临床, 2022, 42(8): 1200-1205.
[9]	刘磊, 李世宝, 张好良. 沉默lnc-SLC2A12-10:1抑制人胃癌细胞系AGS增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(7): 1071-1076.
[10]	钟鸣, 于修义, 郭伟溪, 方正. 麦冬皂苷B抑制人食管鳞状细胞癌细胞系EC9706增殖和迁移[J]. 基础医学与临床, 2022, 42(7): 1053-1059.
[11]	康有力, 赵丹, 杜文静, 李莉. SIRT5通过调控ALDH5A1的琥珀酰化促进人乳腺癌细胞的增殖[J]. 基础医学与临床, 2022, 42(7): 1099-1107.
[12]	白冰, 张海芳, 杨庆良, 秦悦, 周晨龙, 宋歌, 王颖. 下调lncRNA RHPN1-AS1抑制人膀胱癌细胞系T24增殖和迁移[J]. 基础医学与临床, 2022, 42(6): 940-944.
[13]	杜雪梅, 张运梅, 周文婷, 吕宏. miR-655-3p靶向KIF20A抑制人肺腺癌细胞系A549迁移及侵袭[J]. 基础医学与临床, 2022, 42(4): 599-606.
[14]	孙全鹏, 樊超, 展德玺, 范怡明, 孙伟峰. 罗哌卡因抑制人肝癌细胞系Hep3B增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(3): 448-453.
[15]	张健, 张吉炯. LncRNA UNC5B-AS1靶向miR-339-5p调控人肺腺癌细胞系A549增殖和凋亡[J]. 基础医学与临床, 2022, 42(3): 454-460.

miR-99a通过下调RRM2抑制人子宫颈癌HeLa细胞系增殖、迁移和侵袭

miR-99a inhibits the proliferation, migration and invasion of cervical cancer HeLa cell line through down-regulating RRM2

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 14

相关文章 15

编辑推荐

Metrics

本文评价